Quest Diagnostics Inc Decrease in Restricted Cash
Quest Diagnostics Inc (DGX) reported Decrease in Restricted Cash of $25.00 million for the 12-month period ending 2017-12-31, per its 10-K filed 2018-02-23.
Discontinued › Notes
us-gaap:DecreaseInRestrictedCash · last filed 2018-02-23
- Quest Diagnostics Inc decrease in restricted cash for the quarter ending 2017-12-31 was $0.00.
- Quest Diagnostics Inc decrease in restricted cash for the quarter ending 2017-09-30 was $0.00.
- Quest Diagnostics Inc decrease in restricted cash for the quarter ending 2017-06-30 was $0.00.
- Quest Diagnostics Inc decrease in restricted cash for the quarter ending 2017-03-31 was $25.00M.
- Quest Diagnostics Inc decrease in restricted cash for fiscal 2017 was $25.00M.
- Quest Diagnostics Inc decrease in restricted cash for fiscal 2016 was $0.00.
- Quest Diagnostics Inc decrease in restricted cash for fiscal 2015 was $0.00.
| Period end | Decrease in Restricted Cash 3 month | Decrease in Restricted Cash 6 month | Decrease in Restricted Cash 9 month | Decrease in Restricted Cash 12 month |
|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $0.00 derived: sum of 2 quarters · filed 2018-02-23 | $0.00 derived: sum of 3 quarters · filed 2018-02-23 | $25.00M 10-K · filed 2018-02-23 |
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-19 | $0.00 derived: sum of 2 quarters · filed 2017-10-19 | $25.00M 10-Q · filed 2017-10-19 | $25.00M derived: sum of 4 quarters · filed 2018-02-23 |
| 2017-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-25 | $25.00M 10-Q · filed 2017-07-25 | $25.00M derived: sum of 3 quarters · filed 2018-02-23 | $25.00M derived: sum of 4 quarters · filed 2018-02-23 |
| 2017-03-31 | $25.00M 10-Q · filed 2017-04-21 | $25.00M derived: sum of 2 quarters · filed 2018-02-23 | $25.00M derived: sum of 3 quarters · filed 2018-02-23 | $25.00M derived: sum of 4 quarters · filed 2018-02-23 |
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-23 | $0.00 derived: sum of 2 quarters · filed 2018-02-23 | $0.00 derived: sum of 3 quarters · filed 2018-02-23 | $0.00 10-K · filed 2018-02-23 |
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-10-19 | $0.00 derived: sum of 2 quarters · filed 2017-10-19 | $0.00 10-Q · filed 2017-10-19 | |
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-07-25 | $0.00 10-Q · filed 2017-07-25 | ||
| 2016-03-31 | $0.00 10-Q · filed 2017-04-21 | |||
| 2015-12-31 | $0.00 10-K · filed 2018-02-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| Guardant Health, Inc. (GH) | United States | $23.675B | -12.65 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |